Delivery Order SPE2DB22D3301-SPE2DB25FY7YD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,360.48 to AmerisourceBergen Drug Corp for the supply of AVYCAZ 2.5 gram vials, an antibiotic medication used to treat serious bacterial infections. This firm fixed-price contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competed delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical...
- The Defense Logistics Agency awarded a $21,991.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AVYCAZ 2.5 gram vials, with a completion date of September 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AVYCAZ (ceftazidime/avibactam) is an advanced-generation antibiotic used to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,105.03, is a Firm Fixed Price Delivery Order for the supply of AVYCAZ 2.5 gram vials. The contract has a completion date of November 22, 2023 and is not designated with a set-aside. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at thirty thousand six hundred nineteen dollars and thirty-four cents ($30,619.34) to Amerisourcebergen Drug Corporation for 2.5 gram vials of the antibiotic drug AVYCAZ. Place of performance will be Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The single delivery order is for a one day period of performance spanning August 14 to August 15, 2023. No subcontractors or set...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,397 vials of the antibiotic drug AVYCAZ 2.5 grams. The award has a ceiling value of $10,819.00 and is a firm fixed price contract with a performance period ending on March 12, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and is delivering the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $14,731.84 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside competitive award (Contract No. 4568975942) represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract will be performed at...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $55,543.32 to AmerisourceBergen Drug Corp on August 4, 2025, under a firm fixed-price contract with an ultimate completion date of August 5, 2025. This non-set-aside award was competitively awarded and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,963.79 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The delivery order carries no set-aside designation...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order valued at $10,447.93 from the Defense Logistics Agency's Medical Supply Chain on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY7YDDelivery Order
The Defense Logistics Agency awarded a $14,216.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of AVYCAZ 2.5 gram vials, a critical antibiotic pharmaceutical product. The contract was competitively awarded without set-aside designations on July 16, 2025, with an ultimate completion date of July 17, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, supporting military and veteran healthcare systems with an extensive portfolio of pharmaceutical products and medical supplies. The company's $999.9 billion IDC vehicle functions as a comprehensive global pharmaceutical support mechanism enabling the delivery of specialty medications, vaccines, and critical medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities worldwide. The DLA's Pharmaceutical Prime Vendor Global Program Generation V initiative, for which this contract serves as a supporting vehicle, is structured to make multiple regional awards, positioning AmerisourceBergen among key contractors meeting federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.2k | 7/16/25 |